Rectal and vaginal administration routes are used for local as well as systemic drug delivery and can offer some unique advantages. The rectal and vaginal routes belong to the transmucosal routes of drug delivery and thus offer the advantage of bypassing first-pass metabolism. They both have a use in systemic drug delivery when the oral route is not available, or where the drug under consideration is not well suited for oral administration, however these are relatively less popular due to their anogenital nature and privacy aspects.
Our range of Super Refined™ excipients are manufactured using a proprietary process, in which impurities are removed in order to maximise the drug product value. They have been specially designed to enhance the stability, solubility and delivery of APIs through the rectal and vaginal administration routes.
Our excipient portfolio includes: